Follow the people · Insider
Sean F. Moran
Sean F. Moran files insider transactions with the SEC as a chief financial officer of Corbus Pharmaceuticals Holdings (CRBP). We hold 2 disclosed purchases and sales filed since 9 December 2008, 1 of them in the last 90 days.
- Files forCRBP
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure10 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 November 2014 — 7 August 2026Chief Financial Officer · Corbus Pharmaceuticals Holdings (CRBP)100 Form 4 lines · source: SEC Form 4
- Filed 29 August 2013 — 3 September 2013Acting Chief Financial Officer · Invivo Therapeutics Holdings (NVIV)5 Form 4 lines · source: SEC Form 4
- Filed 8 December 2008 — 17 March 2009Chief Financial Officer · Celsion (CLSN)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
112 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 12,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 410 August 2026Common Stock, par value $0.0001 per share · traded 7 August 2026 · filed 10 August 2026
- ▼ sold on the open market 4,701 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 February 2026Common Stock, par value $0.0001 per share · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 4,701 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 February 2026Common Stock, par value $0.0001 per share · traded 13 February 2026 · filed 18 February 2026
- was granted 28,082 shares of Corbus Pharmaceuticals HoldingsSEC Form 416 January 2026Common Stock, par value $0.0001 per share · traded 14 January 2026 · filed 16 January 2026
- was granted 84,247 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 416 January 2026Stock options (right to buy) · traded 14 January 2026 · filed 16 January 2026
- was granted 84,247 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 416 January 2026Stock options (right to buy) · traded 14 January 2026 · filed 16 January 2026
- was granted 28,082 shares of Corbus Pharmaceuticals HoldingsSEC Form 416 January 2026Common Stock, par value $0.0001 per share · traded 14 January 2026 · filed 16 January 2026
- exercised options over 12,981 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 427 October 2025Stock options (right to buy) · traded 24 October 2025 · filed 27 October 2025
- exercised options over 12,981 shares of Corbus Pharmaceuticals HoldingsSEC Form 427 October 2025Common Stock, par value $0.0001 per share · traded 24 October 2025 · filed 27 October 2025
- ▼ sold on the open market 12,981 shares of Corbus Pharmaceuticals HoldingsSEC Form 427 October 2025Common Stock, par value $0.0001 per share · traded 24 October 2025 · filed 27 October 2025
- ▼ sold on the open market 2,792 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 February 2025Common Stock, par value $0.0001 per share · traded 14 February 2025 · filed 18 February 2025
- was granted 92,500 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 44 February 2025Stock options (right to buy) · traded 31 January 2025 · filed 4 February 2025
- was granted 27,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 44 February 2025Common Stock, par value $0.0001 per share · traded 31 January 2025 · filed 4 February 2025
- exercised options over 1,567 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 June 2024Options to purchase common stock · traded 14 June 2024 · filed 18 June 2024
- exercised options over 7,788 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 June 2024Options to purchase common stock · traded 14 June 2024 · filed 18 June 2024
- exercised options over 6,730 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 June 2024Options to purchase common stock · traded 17 June 2024 · filed 18 June 2024
- exercised options over 1,958 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 June 2024Options to purchase common stock · traded 18 June 2024 · filed 18 June 2024
- exercised options over 1,567 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 14 June 2024 · filed 18 June 2024
- ▼ sold on the open market 1,567 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 14 June 2024 · filed 18 June 2024
- exercised options over 7,788 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 14 June 2024 · filed 18 June 2024
- ▼ sold on the open market 7,788 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 14 June 2024 · filed 18 June 2024
- exercised options over 6,730 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 17 June 2024 · filed 18 June 2024
- ▼ sold on the open market 6,730 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 17 June 2024 · filed 18 June 2024
- exercised options over 1,958 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 18 June 2024 · filed 18 June 2024
- ▼ sold on the open market 1,958 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 June 2024Common Stock, par value $0.0001 per share · traded 18 June 2024 · filed 18 June 2024
- exercised options over 1,787 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 411 April 2024Employee Stock Option (right to buy) · traded 10 April 2024 · filed 11 April 2024
- exercised options over 1,787 shares of Corbus Pharmaceuticals HoldingsSEC Form 411 April 2024Common Stock · traded 10 April 2024 · filed 11 April 2024
- was granted 40,176 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 414 February 2024Stock Option (right to buy) · traded 12 February 2024 · filed 14 February 2024
- was granted 40,176 shares of Corbus Pharmaceuticals HoldingsSEC Form 414 February 2024Common Stock, par value $0.0001 per share · traded 12 February 2024 · filed 14 February 2024
- was granted 934,645 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 415 February 2023Stock Option (right to buy) · traded 13 February 2023 · filed 15 February 2023
- ▲ bought on the open market 20,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 410 August 2022Common Stock · traded 10 August 2022 · filed 10 August 2022
- ▲ bought on the open market 12,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 416 May 2022Common Stock · traded 16 May 2022 · filed 16 May 2022
- ▲ bought on the open market 15,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 410 March 2022Common Stock · traded 10 March 2022 · filed 10 March 2022
- was granted 538,400 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 42 February 2022Stock Option (right to buy) · traded 1 February 2022 · filed 2 February 2022
- was granted 307,300 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 44 February 2021Stock Option (right to buy) · traded 2 February 2021 · filed 4 February 2021
- was granted 307,300 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 44 February 2021Stock Option (right to buy) · traded 2 February 2021 · filed 4 February 2021
- exercised options over 53,610 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 422 December 2020Stock Option (Right to Buy) · traded 18 December 2020 · filed 22 December 2020
- exercised options over 87,500 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 422 December 2020Stock Option (Right to Buy) · traded 21 December 2020 · filed 22 December 2020
- exercised options over 53,610 shares of Corbus Pharmaceuticals HoldingsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 53,610 shares of Corbus Pharmaceuticals HoldingsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- exercised options over 87,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 422 December 2020Common Stock · traded 21 December 2020 · filed 22 December 2020
- ▼ sold on the open market 87,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 422 December 2020Common Stock · traded 21 December 2020 · filed 22 December 2020
- exercised options over 36,923 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 December 2020Stock Option (Right to Buy) · traded 16 December 2020 · filed 18 December 2020
- exercised options over 36,923 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 December 2020Common Stock · traded 16 December 2020 · filed 18 December 2020
- ▼ sold on the open market 36,923 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 December 2020Common Stock · traded 16 December 2020 · filed 18 December 2020
- was granted 226,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 49 March 2020Stock Option(right to buy) · traded 6 March 2020 · filed 9 March 2020
- ▲ bought on the open market 100 shares of Corbus Pharmaceuticals HoldingsSEC Form 414 May 2019Common Stock · traded 14 May 2019 · filed 14 May 2019
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 414 March 2019Common Stock · traded 14 March 2019 · filed 14 March 2019
- was granted 195,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 418 January 2019Stock Option(right to buy) · traded 18 January 2019 · filed 18 January 2019
- ▲ bought on the open market 4,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 415 May 2018Common Stock · traded 15 May 2018 · filed 15 May 2018
- ▲ bought on the open market 3,100 shares of Corbus Pharmaceuticals HoldingsSEC Form 414 March 2018Common Stock · traded 14 March 2018 · filed 14 March 2018
- was granted 175,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 45 January 2018Stock Option(right to buy) · traded 4 January 2018 · filed 5 January 2018
- was granted 175,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 45 January 2018Stock Option(right to buy) · traded 4 January 2018 · filed 5 January 2018
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 413 November 2017Common Stock · traded 10 November 2017 · filed 13 November 2017
- ▲ bought on the open market 2,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 411 August 2017Common Stock · traded 11 August 2017 · filed 11 August 2017
- ▲ bought on the open market 3,300 shares of Corbus Pharmaceuticals HoldingsSEC Form 412 May 2017Common Stock · traded 11 May 2017 · filed 12 May 2017
- ▲ bought on the open market 2,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 413 March 2017Common Stock · traded 13 March 2017 · filed 13 March 2017
- was granted 115,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 43 March 2017Stock Option(right to buy) · traded 1 March 2017 · filed 3 March 2017
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 42 December 2016Common Stock · traded 2 December 2016 · filed 2 December 2016
- was granted 150,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 47 October 2016Stock Option(right to buy) · traded 6 October 2016 · filed 7 October 2016
- ▲ bought on the open market 30,800 shares of Corbus Pharmaceuticals HoldingsSEC Form 48 September 2016Common Stock · traded 8 September 2016 · filed 8 September 2016
- ▲ bought on the open market 17,900 shares of Corbus Pharmaceuticals HoldingsSEC Form 426 August 2016Common Stock · traded 26 August 2016 · filed 26 August 2016
- ▲ bought on the open market 83,960 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 August 2016Common Stock · traded 17 August 2016 · filed 18 August 2016
- ▲ bought on the open market 65,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 August 2016Common Stock · traded 18 August 2016 · filed 18 August 2016
- ▲ bought on the open market 27,250 shares of Corbus Pharmaceuticals HoldingsSEC Form 419 May 2016Common Stock · traded 19 May 2016 · filed 19 May 2016
- ▲ bought on the open market 30,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 May 2016Common Stock · traded 18 May 2016 · filed 18 May 2016
- was granted 175,000 shares of Corbus Pharmaceuticals Holdings (a derivative holding)SEC Form 411 January 2016Stock Option(right to buy) · traded 7 January 2016 · filed 11 January 2016
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 411 December 2015Common Stock · traded 11 December 2015 · filed 11 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 410 December 2015Common Stock · traded 10 December 2015 · filed 10 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 49 December 2015Common Stock · traded 9 December 2015 · filed 9 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 48 December 2015Common Stock · traded 8 December 2015 · filed 8 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 47 December 2015Common Stock · traded 7 December 2015 · filed 7 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 44 December 2015Common Stock · traded 4 December 2015 · filed 4 December 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 43 December 2015Common Stock · traded 2 December 2015 · filed 3 December 2015
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 424 November 2015Common Stock · traded 24 November 2015 · filed 24 November 2015
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 420 November 2015Common Stock · traded 20 November 2015 · filed 20 November 2015
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 November 2015Common Stock · traded 18 November 2015 · filed 18 November 2015
- ▲ bought on the open market 1,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 417 November 2015Common Stock · traded 17 November 2015 · filed 17 November 2015
- ▲ bought on the open market 2,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 416 November 2015Common Stock · traded 16 November 2015 · filed 16 November 2015
- ▲ bought on the open market 5,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 416 September 2015Common Stock · traded 16 September 2015 · filed 16 September 2015
- ▲ bought on the open market 5,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 415 September 2015Common Stock · traded 15 September 2015 · filed 15 September 2015
- ▲ bought on the open market 5,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 414 September 2015Common Stock · traded 14 September 2015 · filed 14 September 2015
- ▲ bought on the open market 5,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 411 September 2015Common Stock · traded 11 September 2015 · filed 11 September 2015
- ▲ bought on the open market 1,400 shares of Corbus Pharmaceuticals HoldingsSEC Form 421 August 2015Common Stock · traded 21 August 2015 · filed 21 August 2015
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 419 August 2015Common Stock · traded 18 August 2015 · filed 19 August 2015
- ▲ bought on the open market 6,500 shares of Corbus Pharmaceuticals HoldingsSEC Form 49 June 2015Common Stock · traded 9 June 2015 · filed 9 June 2015
- ▲ bought on the open market 18,800 shares of Corbus Pharmaceuticals HoldingsSEC Form 422 December 2014Common Stock · traded 18 December 2014 · filed 22 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 December 2014Common Stock · traded 17 December 2014 · filed 18 December 2014
- ▲ bought on the open market 600 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 December 2014Common Stock · traded 17 December 2014 · filed 18 December 2014
- ▲ bought on the open market 1,250 shares of Corbus Pharmaceuticals HoldingsSEC Form 418 December 2014Common Stock · traded 17 December 2014 · filed 18 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 412 December 2014Common Stock · traded 11 December 2014 · filed 12 December 2014
- ▲ bought on the open market 1,200 shares of Corbus Pharmaceuticals HoldingsSEC Form 49 December 2014Common Stock · traded 9 December 2014 · filed 9 December 2014
- ▲ bought on the open market 500 shares of Corbus Pharmaceuticals HoldingsSEC Form 49 December 2014Common Stock · traded 9 December 2014 · filed 9 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 44 December 2014Common Stock · traded 4 December 2014 · filed 4 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 44 December 2014Common Stock · traded 4 December 2014 · filed 4 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 42 December 2014Common Stock · traded 2 December 2014 · filed 2 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 41 December 2014Common Stock · traded 26 November 2014 · filed 1 December 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 426 November 2014Common Stock · traded 25 November 2014 · filed 26 November 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 426 November 2014Common Stock · traded 25 November 2014 · filed 26 November 2014
- ▲ bought on the open market 1,000 shares of Corbus Pharmaceuticals HoldingsSEC Form 426 November 2014Common Stock · traded 25 November 2014 · filed 26 November 2014
- ▲ bought on the open market 20,000 shares of Invivo Therapeutics HoldingsSEC Form 44 September 2013COMMON STOCK · traded 3 September 2013 · filed 4 September 2013
- ▼ sold on the open market 28,000 shares of Invivo Therapeutics HoldingsSEC Form 43 September 2013COMMON STOCK · traded 29 August 2013 · filed 3 September 2013
- ▼ sold on the open market 12,000 shares of Invivo Therapeutics HoldingsSEC Form 43 September 2013COMMON STOCK · traded 30 August 2013 · filed 3 September 2013
- ▲ bought on the open market 28,000 shares of Invivo Therapeutics HoldingsSEC Form 43 September 2013COMMON STOCK · traded 29 August 2013 · filed 3 September 2013
- ▲ bought on the open market 12,000 shares of Invivo Therapeutics HoldingsSEC Form 43 September 2013COMMON STOCK · traded 30 August 2013 · filed 3 September 2013
- ▲ bought on the open market 5,000 shares of CelsionSEC Form 417 March 2009Common Stock · traded 17 March 2009 · filed 17 March 2009
- was granted 6,667 shares of Celsion (a derivative holding)SEC Form 49 February 2009Common Stock Options · traded 19 January 2009 · filed 9 February 2009
- was granted 6,667 shares of Celsion (a derivative holding)SEC Form 49 February 2009Common Stock Options · traded 19 January 2009 · filed 9 February 2009
- was granted 6,666 shares of Celsion (a derivative holding)SEC Form 49 February 2009Common Stock Options · traded 19 January 2009 · filed 9 February 2009
- was granted 5,000 shares of CelsionSEC Form 49 February 2009Common Stock · traded 19 January 2009 · filed 9 February 2009
- was granted 100,000 shares of Celsion (a derivative holding)SEC Form 49 December 2008Common Stock Options · traded 8 December 2008 · filed 9 December 2008
- was granted 25,000 shares of CelsionSEC Form 49 December 2008Common Stock · traded 8 December 2008 · filed 9 December 2008
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.